Fig. 6 | Scientific Reports

Fig. 6

From: Oral administration of antimicrobial peptide MPX can effectively regulate LPS-mediated testicular oxidative stress and blood‒testis barrier damage

Fig. 6

Effect of MPX on the expression of tight junction proteins after blood‒testis barrier injury induced by LPS at Days 20 and 40. (A-C) mRNA expression of Claudin, Occludin, and ZO-1 in testicular tissue at Days 20 and 40 after MPX treatment. (D) Protein expression of N-cadherin, E-cadherin, Slug, Occludin, Vimentin, and TWIST1 in testicular tissue at Days 20 and 40 after MPX treatment. (E–J) Quantitative analysis of protein expression at Days 20 and 40 after MPX treatment (*p < 0.05, **p < 0.01, * represented MPX treatment group vs. LPS group; #p < 0.05, ##p < 0.01, # represented Polymyxin B treatment group vs. LPS group; n = 10 mice/group).

Back to article page